Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

Similar articles for PubMed (Select 22718054)

1.
2.

WITHDRAWN: Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever).

Effa EE, Bukirwa H.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD006083. doi: 10.1002/14651858.CD006083.pub3. Review.

PMID:
21975751
3.

Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever).

Effa EE, Bukirwa H.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006083. doi: 10.1002/14651858.CD006083.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(10):CD006083.

PMID:
18843701
4.

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).

Effa EE, Lassi ZS, Critchley JA, Garner P, Sinclair D, Olliaro PL, Bhutta ZA.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD004530. doi: 10.1002/14651858.CD004530.pub4. Review.

PMID:
21975746
5.

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).

Thaver D, Zaidi AK, Critchley JA, Azmatullah A, Madni SA, Bhutta ZA.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004530. doi: 10.1002/14651858.CD004530.pub3. Review. Update in: Cochrane Database Syst Rev. 2011;(10):CD004530.

PMID:
18843659
6.

A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis.

Thaver D, Zaidi AK, Critchley J, Azmatullah A, Madni SA, Bhutta ZA.

BMJ. 2009 Jun 3;338:b1865. doi: 10.1136/bmj.b1865. Review.

7.

Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).

Thaver D, Zaidi AK, Critchley J, Madni SA, Bhutta ZA.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004530. Review. Update in: Cochrane Database Syst Rev. 2008;(4):CD004530.

PMID:
15846718
8.

A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam.

Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, Phung QT, Doan CD, Nguyen TB, Duong TL, Luong BH, Nguyen TB, Nguyen TA, Pham ND, Mai NL, Phan VB, Vo AH, Nguyen VM, Tran TT, Tran TC, Schultsz C, Dunstan SJ, Stepniewska K, Campbell JI, To SD, Basnyat B, Nguyen VV, Nguyen VS, Nguyen TC, Tran TH, Farrar J.

PLoS One. 2008 May 21;3(5):e2188. doi: 10.1371/journal.pone.0002188.

9.

Efficacy and safety of azithromycin for uncomplicated typhoid fever: an open label non-comparative study.

Aggarwal A, Ghosh A, Gomber S, Mitra M, Parikh AO.

Indian Pediatr. 2011 Jul;48(7):553-6.

PMID:
21555791
10.

Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children.

Frenck RW Jr, Nakhla I, Sultan Y, Bassily SB, Girgis YF, David J, Butler TC, Girgis NI, Morsy M.

Clin Infect Dis. 2000 Nov;31(5):1134-8. Epub 2000 Nov 6.

11.

Treatment of typhoid fever in the 21st century: promises and shortcomings.

Butler T.

Clin Microbiol Infect. 2011 Jul;17(7):959-63. doi: 10.1111/j.1469-0691.2011.03552.x. Review.

12.

Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.

Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, Tung le T, Tham NT, Wain J, Hien TT, Farrar JJ.

Antimicrob Agents Chemother. 2007 Mar;51(3):819-25. Epub 2006 Dec 4.

13.
14.

A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.

Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, Wain J, White NJ, Farrar JJ.

Antimicrob Agents Chemother. 2000 Jul;44(7):1855-9.

15.

Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India.

Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, Khakhria R, Potkar CN, Zelasky MT, Johnson RB.

J Antimicrob Chemother. 1999 Aug;44(2):243-50.

16.

Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents.

Frenck RW Jr, Mansour A, Nakhla I, Sultan Y, Putnam S, Wierzba T, Morsy M, Knirsch C.

Clin Infect Dis. 2004 Apr 1;38(7):951-7. Epub 2004 Mar 12.

17.

Highly resistant Salmonella enterica serovar Typhi with a novel gyrA mutation raises questions about the long-term efficacy of older fluoroquinolones for treating typhoid fever.

Koirala KD, Thanh DP, Thapa SD, Arjyal A, Karkey A, Dongol S, Shrestha UM, Farrar JJ, Basnyat B, Baker S.

Antimicrob Agents Chemother. 2012 May;56(5):2761-2. doi: 10.1128/AAC.06414-11. Epub 2012 Feb 27.

18.

[Intravenous azithromycin for treatment of an uncomplicated typhoid fever suspected primary treatment failure].

Mizuno Y, Sato A, Shimizu H, Nakamura I, Fukushima S, Hamada A, Matsumoto T.

Kansenshogaku Zasshi. 2012 Jul;86(4):427-9. Japanese. No abstract available.

PMID:
22991852
19.

In vitro susceptibility of typhoidal Salmonellae against newer antimicrobial agents: a search for alternate treatment options.

Qaiser S, Irfan S, Khan E, Ahsan T, Zafar A.

J Pak Med Assoc. 2011 May;61(5):462-5.

PMID:
22204180
20.

Meta-analysis of drug treatment for scrub typhus in Asia.

Fang Y, Huang Z, Tu C, Zhang L, Ye D, Zhu BP.

Intern Med. 2012;51(17):2313-20. Epub 2012 Sep 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk